Novavax Inc. (NVAX)
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum
Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates
Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago.
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Outperforms Broader Market: What You Need to Know
Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day.
Shah Capital intends to vote against Novavax's board nominees, executive compensation
Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's upcoming annual meeting, renewing pressure for changes at the vaccine maker.
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Novavax (NVAX) stood at $8.02, denoting a -1.47% move from the preceding trading day.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
